Loading clinical trials...
Loading clinical trials...
Lymph Node Dissection of Gastric Cancer Based on Molecular Imaging of Metastatic Lymph Nodes of Gastric Cancer with 99mTc-3PRGD2 Probes
Conditions
Interventions
99mTc-3PRGD2 Spect-CT scan
Start Date
June 6, 2024
Primary Completion Date
December 31, 2025
Completion Date
December 31, 2025
Last Updated
May 30, 2024
NCT06885697
NCT07328243
NCT06630130
NCT07124754
NCT06732856
NCT07035587
Lead Sponsor
Peking University Cancer Hospital & Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions